PPP

PHARMACOLOG I UPPSALA AB SER. B

No trades
See on Supercharts
Market capitalization
‪6.75 M‬SEK
−0.5925SEK
‪−18.28 M‬SEK
‪9.94 M‬SEK
Beta (1Y)
0.15

About PHARMACOLOG I UPPSALA AB SER. B

CEO
Lars Gusch
Headquarters
Uppsala
Employees (FY)
7
Founded
2007
ISIN
SE0019071812
FIGI
BBG008G8QL75
Pharmacolog i Uppsala AB engages in the provision of quality assurance solutions for safe administration of drugs. Its lead product, DrugLog, focuses on the quality assurance in drug administration in the hospital pharmacy and the clinical ward. The company was founded by Hans Erik Dahlin and Kjell Westerlund on January 15, 2007 and is headquartered in Uppsala, Sweden.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of PHLOG_B is 0.1050 SEK — it has increased by 2.94% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange PHARMACOLOG I UPPSALA AB SER. B stocks are traded under the ticker PHLOG_B.
PHLOG_B stock is 2.86% volatile and has beta coefficient of 0.15. Check out the list of the most volatile stocks — is PHARMACOLOG I UPPSALA AB SER. B there?
Yes, you can track PHARMACOLOG I UPPSALA AB SER. B financials in yearly and quarterly reports right on TradingView.
PHLOG_B stock has risen by 15.13% compared to the previous week, the month change is a 50.00% rise, over the last year PHARMACOLOG I UPPSALA AB SER. B has showed a 93.91% decrease.
PHLOG_B net income for the last quarter is ‪−4.03 M‬ SEK, while the quarter before that showed ‪−4.43 M‬ SEK of net income which accounts for 8.96% change. Track more PHARMACOLOG I UPPSALA AB SER. B financial stats to get the full picture.
Today PHARMACOLOG I UPPSALA AB SER. B has the market capitalization of ‪6.75 M‬, it has decreased by 2.28% over the last week.
No, PHLOG_B doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PHLOG_B shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PHARMACOLOG I UPPSALA AB SER. B stock right from TradingView charts — choose your broker and connect to your account.
PHLOG_B reached its all-time high on Apr 16, 2019 with the price of 16.5660 SEK, and its all-time low was 0.0205 SEK and was reached on Nov 9, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has 7.00 employees. See our rating of the largest employees — is PHARMACOLOG I UPPSALA AB SER. B on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PHARMACOLOG I UPPSALA AB SER. B technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PHARMACOLOG I UPPSALA AB SER. B stock shows the sell signal. See more of PHARMACOLOG I UPPSALA AB SER. B technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PHARMACOLOG I UPPSALA AB SER. B EBITDA is ‪−17.91 M‬ SEK, and current EBITDA margin is −180.48%. See more stats in PHARMACOLOG I UPPSALA AB SER. B financial statements.